Trial Profile
A retrospective trial evaluated the intraoperative efficacy of Dexmedetomidine in patients undergoing non-small cell lung cancer surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- Sponsors Hospira
- 02 Mar 2016 New trial record